| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Sep'18 | Jun'18 |
|---|---|---|---|---|---|---|
Revenue | ||||||
217,830 | 200,462 | 178,346 | 162,997 | 0 | 0 | 0 |
Cost of revenue | ||||||
95,869 | 88,322 | 79,505 | 72,908 | 0 | 0 | 0 |
Gross profit | ||||||
121,961 | 112,140 | 98,841 | 90,089 | 0 | 0 | 0 |
Operating expenses: | ||||||
Research and development | ||||||
50,614 | 46,492 | 42,774 | 38,752 | 0 | 0 | 0 |
Sales and marketing | ||||||
75,226 | 71,097 | 61,836 | 56,249 | 0 | 0 | 0 |
General and administrative | ||||||
46,568 | 41,099 | 34,468 | 28,015 | 0 | 0 | 0 |
Total operating expenses | ||||||
172,408 | 158,688 | 139,078 | 123,016 | 0 | 0 | 0 |
Loss from operations | ||||||
-50,447 | -46,548 | -40,237 | -32,927 | 0 | 0 | 0 |
Interest income | ||||||
3,590 | 3,287 | 2,724 | 1,717 | 0 | 0 | 0 |
Interest expense | ||||||
4,317 | 5,236 | 5,324 | 5,062 | 0 | 0 | 0 |
Other income (expense), net | ||||||
-1,383 | -2,561 | -2,893 | -3,142 | 0 | 0 | 0 |
Loss before income taxes | ||||||
-52,557 | -51,058 | -45,730 | -39,414 | 0 | 0 | 0 |
Income taxes | ||||||
1,192 | 492 | 279 | 268 | 0 | 0 | 0 |
Net loss | ||||||
-53,813 | -51,550 | -45,964 | -39,637 | 0 | 0 | 0 |
Foreign currency translation adjustment | ||||||
- | - | - | 0 | - | - | 0 |
Loss on investments in available-for-sale-securities | ||||||
- | - | - | 0 | - | - | 0 |
Total other comprehensive (loss) income | ||||||
- | - | - | 0 | - | - | 0 |
Comprehensive loss | ||||||
- | - | - | 0 | - | - | 0 |
Net loss attributable to common stockholders | ||||||
- | - | - | 0 | - | - | 0 |
Net loss per share attributable to common stockholders, basic and diluted (in USD per share) | ||||||
-0.13 | 0.02 | -0.13 | -0.26 | -0.38 | -0.35 | -0.24 |
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares) | ||||||
95,401 | 95,089 | 93,240 | 59,781 | 25,290 | 24,529 | 24,127 |